KB
Kaida BioPharma Inc.
SEC filingBiotechnology · Fort Lauderdale, FL
Amount raised$1.6Msold at filing
Total offering$4.1M$2.5M still open
Investors in the raise44count reported to the SEC
FiledSep 1, 2026first sale Oct 24, 2023
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Richard WarburgDirector
Craig PiersonExecutive Officer, Director
Stella VnookDirector
Executive officers, directors and promoters as listed on the Form D.